Cerulean Pharma Inc. Email Format

BiotechnologyMassachusetts, United States11-50 Employees

Cerulean Pharma Inc. is a clinical-stage biotechnology company based in Waltham, Massachusetts, focused on oncology research. It develops nanoparticle-drug conjugates intended to selectively target tumor cells and reduce toxicity to normal tissues, with the aim of enabling combination therapies. The company emphasizes its Dynamic Tumor Targeting platform to build a portfolio of NDCs, including lead candidate CRLX101, which is being explored in multiple clinical trials in combination with other cancer treatments, and CRLX301, currently in a Phase 1/2a study. Cerulean targets cancer researchers and clinicians seeking new approaches to improve treatment selectivity and expand therapeutic options through combination regimens. The organization operates within the biotechnology research industry and is structured to advance its oncology programs from its base in the United States.

Get verified Cerulean Pharma Inc. emails free

Company overview Employee directory